background
novel
influenza
viru
subtyp
swinelineag
swl
transmit
rapidli
mani
region
world
evid
sustain
transmiss
within
countri
rapid
detect
differenti
season
influenza
essenti
instig
appropri
patient
public
health
manag
diseas
surveil
object
develop
rapid
sensit
realtim
revers
transcriptas
polymeras
chain
reaction
rtrtpcr
confirm
swl
studi
design
onestep
rtrtpcr
approach
employ
target
matrix
gene
novel
influenza
swl
valid
panel
season
influenza
swine
influenza
avian
influenza
virus
assay
follow
valid
use
prospect
detect
swl
posit
specimen
recent
outbreak
uk
republ
ireland
result
onestep
swl
matrix
rtrtpcr
success
detect
swl
clinic
specimen
crossreact
season
influenza
subtyp
virus
swine
influenza
swl
matrix
assay
cross
react
swl
matrix
assay
compar
two
assay
use
dilut
seri
panel
untyp
influenza
posit
clinic
sampl
experi
found
assay
compar
sensit
establish
univers
influenza
rtrtpcr
sensit
swl
specif
assay
target
region
conclus
result
demonstr
rtrtpcr
sensit
use
alongsid
exist
univers
influenza
assay
rapidli
detect
novel
swl
viru
april
novel
swinelineag
influenza
swl
infect
report
world
health
organis
center
diseas
control
prevent
cdc
atlanta
two
children
present
febril
respiratori
ill
adjac
counti
southern
california
case
epidemiolog
link
neither
child
exposur
swine
subsequ
phylogenet
characteris
swl
us
index
case
show
viru
uniqu
genom
composit
previous
identifi
six
gene
pa
ha
np
ns
similar
virus
previous
identifi
triplereassort
swine
influenza
virus
north
american
pig
remain
two
gene
na
deriv
eurasian
swine
influenza
virus
particular
gene
constel
never
previous
identifi
human
reservoir
sinc
origin
identif
swl
us
mexico
sustain
human
human
transmiss
seen
countri
rais
concern
futur
pandem
symptom
seen
us
case
outsid
mexico
resembl
normal
seen
influenza
fever
cough
sore
throat
rhinorrhea
headach
myaglia
howev
approxim
patient
vomit
diarrhea
unusu
high
compar
infect
strain
influenza
tabl
primer
probe
sequenc
gener
influenza
swl
rtrtpcr
assay
target
gene
forward
primer
revers
primer
probe
gener
influenza
matrix
aagacaagaccaatyctgtcacctct
tctacgytgcagtccycgct
famtyacgctcaccgtgcccagtgbhq
influenza
swl
matrix
tgtgccacttgtgaacagattg
ctgattagtggattggtggtagtagc
tgattcacagcatcggtctcacagacag
bhq
swl
na
gene
segment
sequenc
date
suggest
viru
fulli
suscept
neuraminidas
inhibitor
oseltamivir
zanamivir
howev
gene
sequenc
shown
resist
adamantan
emerg
swl
viru
ramif
exist
diagnost
type
pcr
method
genet
differ
mention
may
result
failur
detect
andor
type
new
viru
influenza
pcr
assay
use
unit
kingdom
target
conserv
region
gene
therefor
detect
influenza
establish
subtyp
includ
newli
emerg
swl
howev
method
need
compliment
rapid
type
test
distinguish
season
influenza
swl
articl
describ
develop
genebas
swl
realtim
revers
transcriptas
polymeras
chain
reaction
rtrtpcr
assay
crossreact
human
season
influenza
virus
subtyp
use
techniqu
confirm
swl
infect
identifi
transmiss
event
novel
viru
develop
rapid
sensit
rtrtpcr
confirm
swl
valid
potenti
cross
reactviti
season
influenza
enzoot
swine
avian
compar
end
point
detect
limit
newli
develop
assay
establish
diagnost
assay
detect
influenza
virus
recent
publish
swl
specif
type
method
prospect
test
specimen
recent
confirm
case
swl
unit
kingdom
republ
ireland
final
compar
newli
develop
assay
swl
specif
type
assay
clinic
sampl
influenza
posit
untyp
time
test
swl
rtrtpcr
assay
design
target
segment
encod
matrix
protein
gene
use
sequenc
primer
express
version
appli
biosystem
chosen
primer
see
tabl
amplifi
amplicon
bioinformat
analysi
use
blast
clustal
align
show
signific
homolog
human
gene
sequenc
numer
mutat
present
homolog
gene
region
season
influenza
subtyp
virus
specif
assay
assess
retrospect
use
panel
season
influenza
sampl
n
swine
avian
virus
also
includ
panel
pool
contain
follow
commonli
encount
respiratori
pathogen
also
test
influenza
b
influenza
c
parainfluenza
human
metapneumoviru
respiratori
syncyti
viru
mycoplasma
pneumonia
rhinoviru
coronavirus
endpoint
detect
limit
new
swl
rtrtpcr
directli
compar
wide
use
univers
influenza
rtrtpcr
assay
swl
specif
rtrtpcr
use
dilut
seri
swl
clinic
sampl
univers
influenza
rtrtpcr
assay
target
matrix
region
viru
use
frontlin
diagnost
test
influenza
viru
detect
glasgow
dublin
virolog
laboratori
particip
variou
eqa
scheme
shown
assay
detect
influenza
virus
human
anim
high
sensit
swl
specif
rtrtpcr
implement
health
protect
agenc
affili
laboratori
england
swl
matrix
assay
assess
prospect
end
april
west
scotland
specialist
virolog
centr
assay
ran
alongsid
routin
influenza
rtrtpcr
use
test
sampl
suspect
case
contact
swl
case
dublin
assay
use
test
sampl
influenza
posit
could
type
influenza
rtrtpcr
sampl
test
swl
posit
use
swl
assay
test
sequenc
submit
health
protect
agenc
confirm
purpos
final
assess
compris
compar
swl
matrix
assay
swl
specif
assay
sampl
influenza
posit
use
univers
influenza
rtrtpcr
sampl
sent
wossvc
first
week
june
taken
contact
confirm
case
swl
untyp
time
test
total
nucleic
acid
extract
respiratori
specimen
use
qiaamp
viral
rna
mini
kit
qiagen
crawley
unit
kingdom
accord
manufactur
instruct
oligonucleotid
primer
probe
tibmolbiol
berlin
germani
swl
univers
influenza
rtrtpcr
assay
outlin
tabl
assay
use
primer
final
concentr
nm
probe
nm
l
l
reaction
volum
onestep
rtrtpcr
perform
l
l
rna
extract
platinum
onestep
qrtpcr
kit
invitrogen
abi
prism
sd
realtim
platform
appli
biosystem
follow
thermal
profil
use
singl
cycl
revers
transcript
min
c
min
c
revers
transcriptas
inactiv
dna
polymeras
activ
follow
amplif
cycl
c
min
c
annealingextens
step
swl
specif
rtrtpcr
carri
describ
elsewher
data
acquisit
occur
anneal
step
cycl
threshold
cycl
ct
sampl
calcul
determin
point
fluoresc
exceed
threshold
limit
specif
swl
matrix
protein
gene
assay
evalu
use
panel
compris
season
influenza
avian
swine
influenza
virus
tabl
crossreact
season
influenza
neg
neg
swine
influenza
commonli
encount
respiratori
pathogen
observ
swl
assay
howev
crossreact
avian
influenza
comparison
univers
influenza
assay
swl
assay
found
slightli
lower
endpoint
detect
limit
detect
dilut
one
two
occas
influenza
univers
assay
detect
dilut
occas
tabl
swl
specif
rtrtpcr
least
sensit
three
assay
endpoint
log
less
univers
swl
matrix
assay
sinc
emerg
swl
unitl
may
sampl
suspect
case
contact
test
wossvc
glasgow
sampl
test
use
frontlin
univers
matrix
swl
rtrtpcr
assay
total
case
influenza
detect
scotland
frontlin
assay
use
wossvc
subtyp
season
neg
swl
assay
eleven
found
posit
swl
assay
tabl
could
type
use
season
subtyp
rtpcr
assay
subsequ
confirm
swl
posit
health
protect
agenc
period
seven
case
influenza
detect
ireland
four
subtyp
season
influenza
subtyp
subtyp
wherea
three
untyp
use
new
assay
found
swl
posit
also
broad
rang
viral
load
evidenc
ct
rang
sampl
tabl
genbank
access
number
final
comparison
assess
swl
matrix
assay
swl
specif
assay
clinic
sampl
test
posit
influenza
use
univers
matrix
test
tabl
sampl
submit
wossvc
first
week
june
type
swl
use
matrix
assay
total
sampl
fail
detect
swl
specif
assay
sampl
ct
valu
univers
influenza
swl
matrix
assay
major
uncertainti
still
exist
regard
transmiss
virul
swl
warrant
develop
new
methodolog
detect
viru
establish
type
method
nucleotid
sequenc
sensit
inform
prolong
influenc
infect
control
public
health
procedur
articl
describ
develop
rapid
sensit
rtrtpcr
assay
detect
emerg
swl
viru
swl
matrix
assay
cross
react
season
influenza
strain
current
circul
subtyp
swine
influenza
commonli
encount
respiratori
pathogen
howev
observ
swl
matrix
test
detect
influenza
subtyp
probabl
due
avian
ancestri
eurasian
gene
swl
studi
also
highlight
nonspecif
relat
avian
strain
influenza
howev
sinc
avian
influenza
virus
circul
human
uk
present
nonspecif
assay
pose
particular
problem
routin
use
sampl
high
risk
avian
influenza
posit
also
test
use
realtim
assay
order
rule
viru
sensit
swl
matrix
assay
compar
frontlin
univers
influenza
rtrtpcr
test
routin
use
dublin
glasgow
test
dilut
seri
clinic
sampl
assay
found
log
sensit
swl
specif
rtrtpcr
assay
lower
sensit
swl
specif
assay
confirm
compar
swl
matrix
assay
untyp
influenza
posit
clinic
sampl
base
result
shown
univers
swl
matrix
assay
sensit
assay
great
use
detect
type
swl
implement
assay
use
detect
case
swl
confirm
swl
methodsspecialist
centr
rapid
swl
diagnost
test
design
implement
highlight
one
main
advantag
inhous
molecular
diagnost
method
enabl
glasgow
dublin
implement
assay
within
day
first
uk
case
detect
use
greatli
enhanc
public
health
respons
emerg
swl
scotland
republ
ireland
abl
rapidli
screen
sampl
patient
suspect
travelassoci
swl
result
infect
could
identifi
quickli
public
health
intervent
implement
minimis
risk
potenti
spread
test
also
use
screen
contact
case
play
import
role
detect
transmiss
swl
either
index
case
contact
contact
author
declar
conflict
interest
